Recommendations for SARS-CoV-2 testing in different clinical situations
Medical diagnostics play a major role in countering the Covid-19 pandemic. Various diagnostic tools are available for different diagnostic purposes, and discussions about which tool to implement in which case come at a cost of valuable time and resources, when both are of exponential essence. The differing approaches stem from the fact that the novel coronavirus is approached with novel test solutions – newly developed, they have yet to prove their advantages and disadvantages in medical practice.
At SYNLAB, we are leveraging our diagnostics experience and capabilities to support our public health partners in breaking chains of infection around the world. For us, that also means continuously evaluating the available testing methods and procedures and specifying their respective implementation in
SYNLAB scientists have drawn up the following recommendation for testing in the beforementioned clinical situations:
1. Diagnosis of acute Covid-19 illness in symptomatic patients
2. Investigation of asymptomatic carriers and contacts
Recommendations for detecting infections in individuals without symptoms and tracing the spread of SARS-CoV-2 through their contacts.
a) Investigation of asymptomatic carriers
b) Investigation of asymptomatic contacts
3. Follow-up of hospitalized patients
4. Hospital discharge
5. Healthcare professionals
There is a variety of rapid tests for SARS-CoV-2 antibodies with different quality levels. As medical professionals reported mixed experiences with those fast antibody tests, we generally recommend reaching out to the local lab, if any questions related to antibody testing occur. In principle, the results of serological laboratory tests for antibodies are more reliable than the results drawn from rapid antibody tests.
Determining the right test in the right situation at the right time frees up resources, conserves capacities and keeps us that crucial one step ahead in managing the pandemic and recovering from this global crisis.
Coronavirus disease (COVID-19) Technical guidance: The Unity Studies: Early Investigations Protocols, WHO, 2020
Coronavirus disease (COVID-19) outbreak: rights, roles and responsibilities of health workers, including key considerations for occupational safety and health, WHO, 2020
Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19), US Center for Disease Control and Prevention, 2020
Criteria to Guide Evaluation and Laboratory Testing for COVID-19, US Center for Disease Control and Prevention, 2020
Coronavirus disease 2019 (COVID-19) situation summary. US Center for Disease Control and Prevention, 2020
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature medicine, 04.2020,26: Vol 4, 506-510 DOI: 10.1038/s41591-020-0822-7 Wu, J T
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020 Mar 28. pii: ciaa344. doi: 10.1093/cid/ciaa344. [Epub ahead of print], Zhao J et al.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges. J. Clin. Microbiol. doi:10.1128/JCM.00512-20, Yi-Wei Tang et al
Stability issues of RT‐PCR testing of SARS‐CoV‐2 forhospitalized patients clinically diagnosed with COVID‐19. J Medical Virology DOI: 10.1002/jmv.25786 Yafang Li et al.
Detection of antibodies against SARS-CoV-2 in patients with COVID-19. J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25820. [Epub ahead of print] Du Z et al.